BTC Health Limited (BTC.AX)
AUD 0.07
(9.23%)
AUD 0.07
(9.23%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 203.94 Thousand AUD | 26.09% |
| 2023 | 161.74 Thousand AUD | 3.94% |
| 2022 | 155.6 Thousand AUD | -92.75% |
| 2021 | 2.14 Million AUD | 841.16% |
| 2020 | 228.13 Thousand AUD | -39.63% |
| 2019 | 377.86 Thousand AUD | 10.35% |
| 2018 | 342.43 Thousand AUD | -50.26% |
| 2017 | 688.43 Thousand AUD | 215.81% |
| 2016 | 217.98 Thousand AUD | 1113.4% |
| 2015 | 17.96 Thousand AUD | -5.33% |
| 2014 | 18.97 Thousand AUD | 39.09% |
| 2013 | 13.64 Thousand AUD | -95.96% |
| 2012 | 337.53 Thousand AUD | -90.81% |
| 2011 | 3.67 Million AUD | 6020.0% |
| 2010 | 60 Thousand AUD | -22.08% |
| 2009 | 77 Thousand AUD | -1.28% |
| 2008 | 78 Thousand AUD | -86.02% |
| 2007 | 558 Thousand AUD | -69.71% |
| 2006 | 1.84 Million AUD | 854.4% |
| 2005 | 193 Thousand AUD | -87.18% |
| 2004 | 1.5 Million AUD | 413.99% |
| 2003 | 293 Thousand AUD | -2.01% |
| 2002 | 299 Thousand AUD | -72.92% |
| 2001 | 1.1 Million AUD | 25.74% |
| 2000 | 878 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q4 | 203.94 Thousand AUD | 0.0% |
| 2024 Q2 | 177.65 Thousand AUD | 0.0% |
| 2024 FY | 203.94 Thousand AUD | 26.09% |
| 2023 FY | 161.74 Thousand AUD | 3.94% |
| 2023 Q4 | 161.74 Thousand AUD | 0.0% |
| 2023 Q2 | 162.61 Thousand AUD | 0.0% |
| 2022 Q4 | 155.6 Thousand AUD | 0.0% |
| 2022 FY | 155.6 Thousand AUD | -92.75% |
| 2022 Q2 | 151.15 Thousand AUD | 0.0% |
| 2021 Q2 | 171.99 Thousand AUD | 0.0% |
| 2021 Q4 | 2.14 Million AUD | 0.0% |
| 2021 FY | 2.14 Million AUD | 841.16% |
| 2020 FY | 228.13 Thousand AUD | -39.63% |
| 2020 Q2 | 154.15 Thousand AUD | 0.0% |
| 2020 Q4 | 228.13 Thousand AUD | 0.0% |
| 2019 FY | 377.86 Thousand AUD | 10.35% |
| 2019 Q2 | 252.36 Thousand AUD | 0.0% |
| 2019 Q4 | 377.86 Thousand AUD | 0.0% |
| 2018 FY | 342.43 Thousand AUD | -50.26% |
| 2018 Q2 | 274.85 Thousand AUD | 0.0% |
| 2018 Q4 | 342.43 Thousand AUD | 0.0% |
| 2017 Q2 | 221.13 Thousand AUD | 0.0% |
| 2017 FY | 688.43 Thousand AUD | 215.81% |
| 2017 Q4 | 688.43 Thousand AUD | 0.0% |
| 2016 Q4 | 217.98 Thousand AUD | 0.0% |
| 2016 FY | 217.98 Thousand AUD | 1113.4% |
| 2016 Q2 | 219.37 Thousand AUD | 0.0% |
| 2015 Q2 | 12.09 Thousand AUD | 0.0% |
| 2015 Q4 | 17.96 Thousand AUD | 0.0% |
| 2015 FY | 17.96 Thousand AUD | -5.33% |
| 2014 FY | 18.97 Thousand AUD | 39.09% |
| 2014 Q4 | 18.97 Thousand AUD | 0.0% |
| 2014 Q2 | 11.38 Thousand AUD | 0.0% |
| 2013 Q4 | 13.64 Thousand AUD | 0.0% |
| 2013 Q3 | 13.64 Thousand AUD | -67.73% |
| 2013 Q1 | 42.27 Thousand AUD | -87.47% |
| 2013 Q2 | 42.27 Thousand AUD | 0.0% |
| 2013 FY | 13.64 Thousand AUD | -95.96% |
| 2012 FY | 337.53 Thousand AUD | -90.81% |
| 2012 Q4 | 337.53 Thousand AUD | 0.0% |
| 2011 Q4 | 3.67 Million AUD | 0.0% |
| 2011 FY | 3.67 Million AUD | 6020.0% |
| 2010 Q4 | 60 Thousand AUD | 0.0% |
| 2010 FY | 60 Thousand AUD | -22.08% |
| 2009 Q4 | 77 Thousand AUD | 0.0% |
| 2009 FY | 77 Thousand AUD | -1.28% |
| 2008 Q4 | 78 Thousand AUD | 0.0% |
| 2008 FY | 78 Thousand AUD | -86.02% |
| 2007 FY | 558 Thousand AUD | -69.71% |
| 2007 Q4 | 558 Thousand AUD | 0.0% |
| 2006 FY | 1.84 Million AUD | 854.4% |
| 2006 Q4 | 1.84 Million AUD | 0.0% |
| 2005 FY | 193 Thousand AUD | -87.18% |
| 2005 Q4 | 193 Thousand AUD | 0.0% |
| 2004 Q4 | 1.5 Million AUD | 0.0% |
| 2004 FY | 1.5 Million AUD | 413.99% |
| 2003 Q4 | 293 Thousand AUD | 0.0% |
| 2003 FY | 293 Thousand AUD | -2.01% |
| 2002 FY | 299 Thousand AUD | -72.92% |
| 2002 Q4 | 299 Thousand AUD | 0.0% |
| 2001 Q4 | 1.1 Million AUD | 0.0% |
| 2001 FY | 1.1 Million AUD | 25.74% |
| 2000 FY | 878 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 4.22 Million AUD | 95.178% |
| Anatara Lifesciences Ltd | 306.84 Thousand AUD | 33.535% |
| Zelira Therapeutics Limited | 9.35 Million AUD | 97.82% |
| Biome Australia Limited | 5.37 Million AUD | 96.204% |
| Patrys Limited | 691.36 Thousand AUD | 70.501% |
| Orthocell Limited | 22.08 Million AUD | 99.076% |
| Imugene Limited | 33.14 Million AUD | 99.385% |
| Noxopharm Limited | 1.28 Million AUD | 84.173% |
| PYC Therapeutics Limited | 10.18 Million AUD | 97.997% |
| Chimeric Therapeutics Limited | 12.8 Million AUD | 98.407% |
| Prescient Therapeutics Limited | 2.32 Million AUD | 91.23% |
| Proteomics International Laboratories Limited | 1.62 Million AUD | 87.456% |
| Cynata Therapeutics Limited | 1.17 Million AUD | 82.584% |
| CSL Limited | 27.88 Billion AUD | 99.999% |
| Arovella Therapeutics Limited | 2.05 Million AUD | 90.083% |
| Bio-Gene Technology Limited | 368.44 Thousand AUD | 44.646% |
| Clinuvel Pharmaceuticals Limited | 28.11 Million AUD | 99.275% |
| Starpharma Holdings Limited | 8.69 Million AUD | 97.655% |
| Nanollose Limited | 465.64 Thousand AUD | 56.201% |
| Memphasys Limited | 5.59 Million AUD | 96.353% |
| Invex Therapeutics Ltd | 431.63 Thousand AUD | 52.749% |
| NeuroScientific Biopharmaceuticals Limited | 85.68 Thousand AUD | -138.026% |
| Amplia Therapeutics Limited | 3.42 Million AUD | 94.048% |
| Botanix Pharmaceuticals Limited | 3.73 Million AUD | 94.535% |
| Island Pharmaceuticals Limited | 1.04 Million AUD | 80.495% |
| Race Oncology Limited | 1.91 Million AUD | 89.358% |
| Nyrada Inc. | 855.63 Thousand AUD | 76.164% |
| Telix Pharmaceuticals Limited | 249.39 Million AUD | 99.918% |
| Dimerix Limited | 13.89 Million AUD | 98.532% |
| PharmAust Limited | 896.6 Thousand AUD | 77.253% |
| Immutep Limited | 10.97 Million AUD | 98.142% |
| Clarity Pharmaceuticals Ltd | 8.33 Million AUD | 97.552% |
| Alterity Therapeutics Limited | 5.42 Million AUD | 96.241% |
| Acrux Limited | 5.68 Million AUD | 96.414% |
| Neuren Pharmaceuticals Limited | 42.76 Million AUD | 99.523% |
| Biotron Limited | 737.5 Thousand AUD | 72.346% |
| Tissue Repair Ltd | 1.35 Million AUD | 84.903% |
| AdAlta Limited | 3.54 Million AUD | 94.243% |
| Radiopharm Theranostics Limited | 44.68 Million AUD | 99.544% |
| Hexima Limited | 248.67 Thousand AUD | 17.984% |
| AnteoTech Limited | 4.07 Million AUD | 94.995% |
| Paradigm Biopharmaceuticals Limited | 3.58 Million AUD | 94.31% |
| Recce Pharmaceuticals Ltd | 15.89 Million AUD | 98.717% |
| Avecho Biotechnology Limited | 941.54 Thousand AUD | 78.339% |
| Actinogen Medical Limited | 1.61 Million AUD | 87.375% |
| Immuron Limited | 2.84 Million AUD | 92.82% |
| Argenica Therapeutics Limited | 2.42 Million AUD | 91.596% |